Search Results - "Kintzing, James"

  • Showing 1 - 14 results of 14
Refine Results
  1. 1

    Engineered knottin peptides as diagnostics, therapeutics, and drug delivery vehicles by Kintzing, James R, Cochran, Jennifer R

    Published in Current opinion in chemical biology (01-10-2016)
    “…[Display omitted] •Knottins are small constrained peptides with ultra-high stability.•New binding epitopes can be introduced into natural knottins using…”
    Get full text
    Journal Article
  2. 2

    Balancing Cationic and Hydrophobic Content of PEGylated siRNA Polyplexes Enhances Endosome Escape, Stability, Blood Circulation Time, and Bioactivity in Vivo by Nelson, Christopher E, Kintzing, James R, Hanna, Ann, Shannon, Joshua M, Gupta, Mukesh K, Duvall, Craig L

    Published in ACS nano (22-10-2013)
    “…A family of pH-responsive diblock polymers composed of poly[(ethylene glycol)-b-[(2-(dimethylamino)ethyl methacrylate)-co-(butyl methacrylate)],…”
    Get full text
    Journal Article
  3. 3

    Integrin-Targeting Knottin Peptide-Drug Conjugates Are Potent Inhibitors of Tumor Cell Proliferation by Cox, Nick, Kintzing, James R., Smith, Mark, Grant, Gerald A., Cochran, Jennifer R.

    Published in Angewandte Chemie International Edition (16-08-2016)
    “…Antibody–drug conjugates (ADCs) offer increased efficacy and reduced toxicity compared to systemic chemotherapy. Less attention has been paid to peptide–drug…”
    Get full text
    Journal Article
  4. 4

    An engineered ultrahigh affinity bi‐paratopic uPAR targeting agent confers enhanced tumor targeting by Cherf, Gerald M., Lee, Robert B., Mehta, Nishant, Clifford, Claire, Torres, Kathleen, Kintzing, James R., Cochran, Jennifer R.

    Published in Biotechnology and bioengineering (01-10-2024)
    “…Urokinase‐type plasminogen activator receptor (uPAR) is overexpressed on tumor cells in multiple types of cancer and contributes to disease progression and…”
    Get full text
    Journal Article
  5. 5

    Emerging Strategies for Developing Next-Generation Protein Therapeutics for Cancer Treatment by Kintzing, James R, Filsinger Interrante, Maria V, Cochran, Jennifer R

    “…Protein-based therapeutics have been revolutionizing the oncology space since they first appeared in the clinic two decades ago. Unlike traditional…”
    Get full text
    Journal Article
  6. 6

    Targeted Drug Delivery with an Integrin-Binding Knottin-Fc-MMAF Conjugate Produced by Cell-Free Protein Synthesis by Currier, Nicolas V, Ackerman, Shelley E, Kintzing, James R, Chen, Rishard, Filsinger Interrante, Maria, Steiner, Alexander, Sato, Aaron K, Cochran, Jennifer R

    Published in Molecular cancer therapeutics (01-06-2016)
    “…Antibody-drug conjugates (ADC) have generated significant interest as targeted therapeutics for cancer treatment, demonstrating improved clinical efficacy and…”
    Get full text
    Journal Article
  7. 7

    Structural Basis of the Differential Binding of Engineered Knottins to Integrins αVβ3 and α5β1 by Van Agthoven, Johannes F., Shams, Hengameh, Cochran, Frank V., Alonso, José L., Kintzing, James R., Garakani, Kiavash, Adair, Brian D., Xiong, Jian-Ping, Mofrad, Mohammad R.K., Cochran, Jennifer R., Arnaout, M. Amin

    Published in Structure (London) (03-09-2019)
    “…Targeting both integrins αVβ3 and α5β1 simultaneously appears to be more effective in cancer therapy than targeting each one alone. The structural requirements…”
    Get full text
    Journal Article
  8. 8

    Sports-related brain injuries: connecting pathology to diagnosis by Pan, James, Connolly, Ian D, Dangelmajer, Sean, Kintzing, James, Ho, Allen L, Grant, Gerald

    Published in Neurosurgical focus (01-04-2016)
    “…Brain injuries are becoming increasingly common in athletes and represent an important diagnostic challenge. Early detection and management of brain injuries…”
    Get full text
    Journal Article
  9. 9

    Inside Cover: Integrin-Targeting Knottin Peptide-Drug Conjugates Are Potent Inhibitors of Tumor Cell Proliferation (Angew. Chem. Int. Ed. 34/2016) by Cox, Nick, Kintzing, James R., Smith, Mark, Grant, Gerald A., Cochran, Jennifer R.

    Published in Angewandte Chemie International Edition (16-08-2016)
    “…A knottin miniprotein first isolated from the seeds of the squirting cucumber has been engineered to bind selectively to tumor‐associated integrin receptors…”
    Get full text
    Journal Article
  10. 10

    Integrin-Targeting Knottin Peptide-Drug Conjugates Are Potent Inhibitors of Tumor Cell Proliferation by Cox, Nick, Kintzing, James R., Smith, Mark, Grant, Gerald A., Cochran, Jennifer R.

    Published in Angewandte Chemie (16-08-2016)
    “…Antibody–drug conjugates (ADCs) offer increased efficacy and reduced toxicity compared to systemic chemotherapy. Less attention has been paid to peptide–drug…”
    Get full text
    Journal Article
  11. 11

    A Bioengineered Peptide that Localizes to and Illuminates Medulloblastoma: A New Tool with Potential for Fluorescence-Guided Surgical Resection by Ackerman, Shelley E, Wilson, Christy M, Kahn, Suzana A, Kintzing, James R, Jindal, Darren A, Cheshier, Samuel H, Grant, Gerald A, Cochran, Jennifer R

    Published in Curēus (Palo Alto, CA) (01-01-2014)
    “…Tumors of the central nervous system are challenging to treat due to the limited effectiveness and associated toxicities of chemotherapy and radiation therapy…”
    Get full text
    Journal Article
  12. 12

    A Toolbox of Peptide-Drug Conjugates for Targeted Chemotherapy by Kintzing, James Reese

    Published 01-01-2019
    “…Traditional cancer chemotherapeutics often have narrow ranges between their effective and toxic doses. To improve efficacy and minimize side effects,…”
    Get full text
    Dissertation
  13. 13

    Innentitelbild: Integrin‐Targeting Knottin Peptide–Drug Conjugates Are Potent Inhibitors of Tumor Cell Proliferation (Angew. Chem. 34/2016) by Cox, Nick, Kintzing, James R., Smith, Mark, Grant, Gerald A., Cochran, Jennifer R.

    Published in Angewandte Chemie (16-08-2016)
    “…Ein Knottin‐Miniprotein das zuerst aus den Samen der Spritzgurke isoliert wurde, konnte für die selektive Bindung an tumorassoziierte Integrinrezeptoren…”
    Get full text
    Journal Article
  14. 14